Ono Pharmaceutical Financials

Ono Pharmaceutical Stock Summary

Ono Pharmaceutical competes with Sanofi ADR, Bristol Myers, AstraZeneca PLC, Gilead Sciences, and Novartis. Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company was founded in 1717 and is headquartered in Osaka, Japan. Ono Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 3687 people.

Ono Pharmaceutical Key Financial Ratios

There are many critical financial ratios that Ono Pharmaceutical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Ono Pharmaceutical reports annually and quarterly.

Ono Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Ono Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Ono Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ono Pharmaceutical competition to find correlations between indicators driving Ono Pharmaceutical's intrinsic value. More Info.Ono Pharmaceutical Co is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.75  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ono Pharmaceutical Co is roughly  1.33 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ono Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Ono Pharmaceutical Systematic Risk

Along with financial statement analysis, the daily predictive indicators of Ono Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ono Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ono Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Ono Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ono Pharmaceutical's daily price indicators and compare them against related drivers.

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.